HRMY
Harmony Biosciences Holdings, Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Net Income
$158.7M
↑ 9.1%
Revenue
$868.5M
↑ 21.5%
Gross Profit
$670.1M
↑ 20.1%
Total Assets
$1.3B
↑ 27.3%
Shareholders' Equity
$870.2M
↑ 32.0%
Cash & Equivalents
$752.5M
↑ 66.1%
Long-term Debt
$163.7M
↓ 8.7%
EPS (Diluted)
$2.71
↑ 8.0%

Recent SEC Filings

Form Type Filed Date Link
144 8/7/2026 View on SEC
10-Q 8/4/2026 View on SEC
8-K 8/4/2026 View on SEC
SCHEDULE 13G 7/31/2026 View on SEC
SCHEDULE 13G/A 7/28/2026 View on SEC
3 7/22/2026 View on SEC
8-K 7/16/2026 View on SEC
144 7/2/2026 View on SEC
144 6/30/2026 View on SEC
144 6/26/2026 View on SEC

Company Information

Field Value
Ticker HRMY
Company Name Harmony Biosciences Holdings, Inc.
CIK 1802665
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (484) 539-9800